VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells
Open Access
- 18 August 2014
- journal article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 211 (9) , 1833-1846
Abstract
The focus of this study is the characterization of human T cell blood–brain barrier migration and corresponding molecular trafficking signatures. We examined peripheral blood and cerebrospinal fluid immune cells from patients under long-term anti–very late antigen-4 (VLA-4)/natalizumab therapy (LTNT) and from CNS specimens. LTNT patients’ cerebrospinal fluid T cells exhibited healthy central-/effector-memory ratios, but lacked CD49d and showed enhanced myeloma cell adhesion molecule (MCAM) expression. LTNT led to an increase of PSGL-1 expression on peripheral T cells. Although vascular cell adhesion molecule-1 (VLA-4 receptor) was expressed at all CNS barriers, P-selectin (PSGL-1-receptor) was mainly detected at the choroid plexus. Accordingly, in vitro experiments under physiological flow conditions using primary human endothelial cells and LTNT patients’ T cells showed increased PSGL-1–mediated rolling and residual adhesion, even under VLA-4 blockade. Adhesion of MCAM+/TH17 cells was not affected by VLA-4 blocking alone, but was abrogated when both VLA-4 and MCAM were inhibited. Consistent with these data, MCAM+ cells were detected in white matter lesions, and in gray matter of multiple sclerosis patients. Our data indicate that lymphocyte trafficking into the CNS under VLA-4 blockade can occur by using the alternative adhesion molecules, PSGL-1 and MCAM, the latter representing an exclusive pathway for TH17 cells to migrate over the blood–brain barrier.Keywords
This publication has 45 references indexed in Scilit:
- Laminin-411 Is a Vascular Ligand for MCAM and Facilitates TH17 Cell Entry into the CNSPLOS ONE, 2012
- Aquaporin 4‐specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporterAnnals of Neurology, 2012
- Efficacy of Anti-Interleukin-2 Receptor Antibody (Daclizumab) in Reducing the Incidence of Acute Rejection After Renal TransplantationNephro-Urology Monthly, 2012
- Fatal PML associated with efalizumab therapyNeurology, 2012
- Th17 lymphocytes traffic to the central nervous system independently of α4 integrin expression during EAEJournal of Experimental Medicine, 2011
- Trafficking of immune cells in the central nervous systemJournal of Clinical Investigation, 2010
- Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cellsNeurology, 2009
- β 1 integrins differentially control extravasation of inflammatory cell subsets into the CNS during autoimmunityProceedings of the National Academy of Sciences, 2009
- Effects of Natalizumab Treatment on Foxp3+ T Regulatory CellsPLOS ONE, 2008
- Spleen Tyrosine Kinase Syk Is Necessary for E-Selectin-Induced αLβ2 Integrin-Mediated Rolling on Intercellular Adhesion Molecule-1Immunity, 2007